Organization · also: Food and Drug Administration
The U.S. Food and Drug Administration is seeking public input on the cyber, AI and patient safety risks involving autonomous and remotely operated ...
CybersecurityHealthcareBanking & FinanceManufacturing & Robotics
The system, which received FDA clearance in February, includes a preoperative planning feature that uses AI to help surgeons design safe and ...
Cardiovascular Business CaRi-Heart was built to evaluate CCTA images for signs of coronary inflammation and provide clinicians with in-depthriskscores. When it does gain …
... threats of AI, the category deserves its own responses. The FDA makes AI threatsmore specific and includes risks related to: • Data Poisoning And …
McDermott Will & Emery Drawing onrisk-based frameworks from the device context, the draft AI drug guidance provides a seven-step framework for developing and executing an …
Medical Product Outsourcing Ibex Medical Analytics Gains FDA 510(k) Clearance. Ibex Prostate Detect is an in vitro diagnostic medical device that uses AI to generate heatmaps …
Medical Product Outsourcing ... that uses AI to guide safe, non-invasive diagnosis of idiopathic pulmonary fibrosis (IPF). The authorization was the first by the FDA for a …
The Healthcare Technology Report....risksunique to AI, including bias and transparency. Developers are encouraged to use the guidance throughout the lifecycle of their devices and …
The National Law Review The Food and Drug Administration's new draft guidance outlines cybersecurityrisksforAI-enabled medical devices and recommends lifecycle …
The company's full annual accounting is scheduled for February 20. Related. Nevro nabs FDA approval for spinal cord stimulator that uses AI to …
Medical Product Outsourcing Ibex Prostate Detect is an in vitro diagnostic medical device that uses AI to generate heatmaps identifying small and rare missed prostatic …
Cardiovascular Business An in-depth analysis out of Stanford explored the many cardiovascularrisksassociated with regular cannabis use. ... New AI model uses ECG images to …
Medical Economics AI is no longer the realm of speculative science fiction—it's here, and it's moving fast. My bold prediction? By 2026, the majority of front desk …
JD Supra The U.S. Food and Drug Administration (FDA) recently published its long-awaited draft guidance on considerations for the use of artificial …
Arent Fox Schiff In its most recent effort to keep pace with advancing technology, the US Food and Drug Administration (FDA) recently issued two draft guidances on …
FDA issues draft guidances on AI in drugs, biologics, and medical devices. Learn about the new recommendations and submission processes for …
In particular, the guidance outlines ariskframework based on a "context of use" of Artificial Intelligence(AI) technology and details the …
The FDA has issued guidelines encouraging manufacturers to identify vulnerabilities and implement safeguards against cyberthreats. The Biden-Harris …
HealthcareManufacturing & RoboticsCybersecurityRegulation & Policy
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the …
In particular, the guidance outlines ariskframework based on a “context of use” of Artificial Intelligence(AI) technology and details the …
The guidances emphasize the need for comprehensive AI policies addressingriskevaluation, data management, transparency, validation, and …
... that uses AI to guide safe, non-invasive diagnosis of idiopathic pulmonary fibrosis (IPF). In early 2024, this signified the first ever FDA …
"As with any digital or software component integrated into a medical device,AI can present cybersecurityrisks," the FDA said. The FDA already …
Sleep Review The FDA has issued draft guidance that provides recommendations for the development ofAI-enabled medical devices …
Manufacturers are eager to incorporate AI into a wide range of medical devices, from cardiac monitors that can spot developing heart problems to …
In its 23-page document, the regulator proposes a “risk-based credibility assessment framework” for using AI in the drug product life cycle. Among the …
AI in Healthcare...AI riskcontrols. The draft document—“Artificial ... risks related to undesirable changes in device performance for AI-enabled medical devices …
Healthcare IT News...risksassociated with AI software in healthcare. Because AI continuously learns and adapts in real-world settings, adaptability poses significant …
The agency issued the alert as part of a pilot to improve the timeliness of communications about actions it believes are likely to be high-risk …
FDA's PCCP final guidance outlines approval process for AI device modifications, aligning with draft, ensuring streamlined regulations …